In Nature this week, researchers at Genentech and Complete Genomics report their analysis of the mutation spectrum of tumor and normal samples from a patient with non-small cell lung cancer. The team found an "approximate rate of 17.7 mutations per megabase throughout the genome," consistent with "the range of previously observed lung-tumor mutation rates," the authors write.